Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2—Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors

Cancer Cell Response to Anthracyclines Effects: Mysteries of the Hidden Proteins Associated with These Drugs

(2012) Jirina Tyleckova et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prognostic Factors in Patients with Stage II/III Breast Cancer Treated with Adjuvant Extension of Neoadjuvant Chemotherapy: A Retrospective Cohort Study with Ten-Years of Follow-Up Data

(2011) Jeryong Kim et al.   Journal of Breast Cancer

ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer

(2011) Jian Pan et al.   Journal of Translational Medicine

Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production

(2011) Claudia R. Oliva et al.   PLoS One

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

(2010) S. Salerno et al.   CURRENT MEDICINAL CHEMISTRY

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

(2010) Catriona Parker et al.   LANCET

An overview of cancer multidrug resistance: a still unsolved problem

(2008) H. Lage   CELLULAR AND MOLECULAR LIFE SCIENCES

Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer

(2007) Eero J. Kumpulainen et al.   ACTA ONCOLOGICA